×
About 2,970 results

ALLMedicine™ Edema Center

Research & Reviews  1,047 results

Implication of Cerebral Small-Vessel Disease on Perihematomal Edema Progress in Patient...
https://doi.org/10.1002/jmri.28240
Journal of Magnetic Resonance Imaging : JMRI; Guo W, Meng L et. al.

Jun 25th, 2022 - Perihematomal edema (PHE) is an important determinant of outcome in spontaneous intracerebral hemorrhage (ICH) due to cerebral small vessel disease (CSVD). However, it is not known to date whether the severity of CSVD is associated with the extent...

Dynamic cerebral blood flow changes with FOXOs stimulation are involved in neuronal dam...
https://doi.org/10.1016/j.brainres.2022.147987
Brain Research; Shi H, Li P et. al.

Jun 21st, 2022 - Acute hypobaric hypoxia (AHH) exposure causes altitude mountain sickness (AMS) and life-threatening high altitude cerebral edema (HACE). Despite decades of research, the role of cerebral blood flow (CBF) changes in the pathophysiology of severe AM...

Radiographic differentiation of secretory meningiomas and WHO grade 2 meningiomas: when...
https://doi.org/10.1016/j.wneu.2022.06.061
World Neurosurgery; Trivedi MM, Momin AA et. al.

Jun 21st, 2022 - Secretory meningioma (SM) is a rare subtype of World Health Organization (WHO) grade 1 meningioma, associated with significant peritumoral brain edema (PTBE). Because of this, SM may be mistaken preoperatively to be a WHO grade 2 meningioma (G2M)....

Imaging-based indices combining disease severity and time from disease onset to predict...
https://doi.org/10.1371/journal.pone.0270111
PloS One; Besutti G, Djuric O et. al.

Jun 17th, 2022 - COVID-19 prognostic factors include age, sex, comorbidities, laboratory and imaging findings, and time from symptom onset to seeking care. The study aim was to evaluate indices combining disease severity measures and time from disease onset to pre...

see more →

Guidelines  1 results

Rationale for the diabetic retinopathy clinical research network treatment protocol for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253487
Ophthalmology , et. al.

Dec 6th, 2011 - To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) in a Diabetic Retinopathy Clinical Research N...

see more →

Drugs  13 results see all →

News  127 results

FDA Approves Brolucizumab for Diabetic Macular Edema
https://www.medscape.com/viewarticle/975248

Jun 8th, 2022 - The US Food and Drug Administration (FDA) has approved brolucizumab (Beovu) for treatment of diabetic macular edema (DME), but included a warning about retinal vasculitis and retinal vascular occlusion. In clinical trials, patients needed fewer in...

FDA Approves Faricimab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
https://www.medscape.com/viewarticle/967524

Jan 28th, 2022 - The US Food and Drug Administration (FDA) today approved faricimab (Vabysmo, Genentech/Roche) to treat diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Compared with antivascular endothelial growth factor (VEGF...

Microbleeds, Age Contribute to ARIA Risk With Aducanumab
https://www.medscape.com/viewarticle/963828

Nov 30th, 2021 - Though primary efficacy results have yet to be published, new safety findings from two large, randomized trials of aducanumab offer details on which patients are more likely to experience complications associated with the controversial Alzheimer's...

Case Reports Underscore Risk for Cerebral Edema, AFCE in Children With COVID-19
https://www.medscape.com/viewarticle/960526

Oct 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An 8-year-old girl who was infected with SARS-CoV-2 died after developing an extremely rare condition known as acute fulminant cerebral edema (AFC...

Diabetic Macular Edema: Mixed Results for Brolucizumab
https://www.medscape.com/viewarticle/958719

Sep 14th, 2021 - Brolucizumab (Beovu) can improve visual acuity of patients with diabetic macular edema (DME) using fewer injections than needed for aflibercept (Eylea), but this advantage may come at the cost of vision-threatening intraocular inflammation for som...

see more →